We analyzed the ex vivo drug sensitivity profiles from short-term fresh tissue tumoroid cultures derived from neuroblastoma patient samples obtained through the INFORM program for expression of senescence signatures and MEK inhibitor sensitivity. This evidence concerns the gene MAP2K7 and neuroblastoma.